| Page 1042 | Kisaco Research

Interview: Regis Cebe, Principal Scientist II, Novartis

Interview: Roberto De Luca, Head of therapeutic Antibodies, Philochem/Philogen

Interview: Jeanette Leusen, Head of the Immunotherapy Group and UMAB, UMCU

Model Risk Management for the Machine Learning Era

Stealth Licensing

Collaborative standardisation and disruptive innovation: summary paper developed by Haris Tsilikas, Max Plank Institute, for 4iP Council.

Why researchers need an IP strategy

Nicholas New

CEO

Optalysys

Yael Alter

Chief Executive Officer

NR Soos Technology

Dr Eve Hanks

Chief Executive Officer & Founder

MI:RNA Diagnostics